Southport Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Southport Capital Management's RGEN Position: Q1 2022 in Review
Southport Capital Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 7,089 shares — an estimated $1.88M sold.
Southport Capital Management first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $1.88M in Q4 2021. 449 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Southport Capital Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Southport Capital Management sold 7,089 Repligen shares in Q1 2022, an estimated $1.88M.
- Southport Capital Management first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
- Southport Capital Management's Repligen position peaked at $1.88M in Q4 2021.
- 449 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.